Similarly, pharmacological inhibition of PKCβ isoform with ruboxistaurin reduced glomerular TGF-β expression and decreased fibronectin and collagen IV deposition fibrosis in experimental DN [287,288]. Here, PRKCB is linked to liver dysplastic nodule.